Journal of Acupuncture Research

Korean Acupuncture & Moxibustion Medicine Society (대한침구의학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Research Trends in Korean Medicine Treatment for Guillain-Barre Syndrome in Korea

  • Jang, Hyun Jin (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, So Jeong (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, Min Ju (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Choi, Hyeon Kyu (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Lee, Young Rok (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Cha, Hyun Ji (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jeong, Jeong Kyo (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jeon, Ju Hyun (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, Young Il (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University)
  • Received : 2022.07.06
  • Accepted : 2022.08.10
  • Published : 2022.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

This review aimed to analyze Korean medicine treatment (KMT) methods used for Guillain-Barre syndrome (GBS) in studies from January 1, 2010, to December 21, 2021. Five online databases (KISS, SCIENCEON, DBpia, RISS, KMbase) were searched for GBS-related studies. A total of 14 case reports were selected. Various treatment methods for GBS such as acupuncture, herbal medicine, moxibustion, and cupping have been reported, and some included Western medication. Herbal medicine and acupuncture were the most frequently used treatment methods. The most common prescription for GBS was Shipjeondaebotang Gami, the most common herb used was Glycyrrhizae radix et rhizome, and the most common acupoints were ST36, LI11, TE5, and LI4. In moxibustion treatment for GBS, CV4 was commonly used, and in cupping treatment the low back and back-shu points and were mostly used. Further studies on Korean medicine treatment of GBS are necessary for standardization of treatment.

Keywords

References

  1. Pritchard J, Hughes RA. Guillain-Barre syndrome. Lancet 2004;363:2186-2188. https://doi.org/10.1016/S0140-6736(04)16512-4
  2. Hughes RAC, Rees JH. Clinical and epidemiological features of Guillain-Barre syndrome. J Infect Dis 1997;176:92-98.
  3. Bogliun G, Beghi E. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand 2004;110:100-106. https://doi.org/10.1111/j.1600-0404.2004.00272.x
  4. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27:21-24.
  5. Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998;64:74-77. https://doi.org/10.1136/jnnp.64.1.74
  6. The Guillain-Barre Syndrome Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology 1985;35:1096-1104. https://doi.org/10.1212/WNL.35.8.1096
  7. Jain RS, Kumar S, Aggarwal R, Kookna JC. Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain-Barre syndrome. Oxf Med Case Rep 2014;7:132-134.
  8. Kim AY, Lee H, Lee YM, Kang HY. Epidemiological features and economic burden of Guillain-Barre syndrome in South Korea: A nationwide population-based study. J Clin Neurol 2021;17:257-264. [in Korean]. https://doi.org/10.3988/jcn.2021.17.2.257
  9. Kim HJ, Lee EJ, Lee SH, Chang GT. A literature study on treatment of Guillain-Barre syndrome based on traditional Chinese medicine journals. J Pediatr Korean Med 2015;29:21-31. [in Korean]. https://doi.org/10.7778/jpkm.2015.29.3.021
  10. Heo GY, Lee C, Cho IH, Kang HK, Kim MH, Kim SY et al. A case report of a patient with Guillain-Barre syndrome who complained of quadriplegia. J Int Korean Med 2021;42:1009-1019. [in Korean]. https://doi.org/10.22246/jikm.2021.42.5.1009
  11. Won SY, Kim HY, Kim JH, Ryu JY, Jung ES, Yoo HR et al. A case report of a patient with Guillain-Barre syndrome complaining of limb weakness and facial paralysis that improved after Korean medicine treatment. J Int Korean Med 2021;42:695-706. [in Korean]. https://doi.org/10.22246/jikm.2021.42.4.695
  12. Cha HJ, Kim BS, Lee YJ, Kim HB, Sung KJ, Lee YR et al. A patient with Guillain-Barre syndrome treated with combined Korean medicine treatments. J Acupunct Res 2021;38:245-256. https://doi.org/10.13045/jar.2021.00171
  13. Ahn JY, Sim SS, Jeong S, Shin YJ, Moon BS, Yun JM. A case report of a patient with Guillain-Barre syndrome complaining of quadriplegia and anorexia improved by Korean medicine treatment. J Int Korean Med 2020;41:769-776. [in Korean]. https://doi.org/10.22246/jikm.2020.41.5.769
  14. Lee HS, Kim DR, Shim SS, Baek DG, Yun JM, Moon BS. A case report on a patient with Guillain-Barre syndrome complaining of quadriplegia and paresthesia, which improved after Korean medicine treatment. J Int Korean Med 2019;40:1210-1218. [in Korean]. https://doi.org/10.22246/jikm.2019.40.6.1210
  15. Roh JY, Jang JW, Lee GE, Hong JS, Kim DJ. A clinical case study of Guillain-Barre syndrome with chronic progression. J Int Korean Med 2018;38:76-83. [in Korean].
  16. Park SM, Cho SW. A case of combined Korean medicine treatment for recurrent limb weakness after Guillain-Barre syndrome improvement: Case report. J Korean Med Rehabil 2019;29:135-142. [in Korean].
  17. Lee YR, Kim KS, Choi HS, Kim SM. A case report of patient with Guillain-Barre syndrome complaining of fatigue and tingling improved by Korean medicine treatment. J Int Korean Med 2017;38:719-726. [in Korean]. https://doi.org/10.22246/jikm.2017.38.5.719
  18. Hwang DG, Park SM, Kim EJ, Kim JY. Case report of patients diagnosed with Guillain-Barre syndrome improved by traditional Korean medical treatment. J Int Korean Med 2016;37:305-314. [in Korean].
  19. Heo I, Heo KH, Hwang EH. A case report on patient with Guillain-Barre syndrome improved by Korean medical combined treatment. J Korean Med Rehabilitation 2015;25;95-101. [in Korean]. https://doi.org/10.18325/jkmr.2015.25.1.095
  20. Kim KW, Kim SS, Lee JS, Chung SH. A clinical case study on Guillain-Barre syndrome complaining both lower extremity weakness with oriental medical treatment. J Korea Chuna Man Med Spine Nerves 2011;6:27-33. [in Korean].
  21. Huh G, Lee YC, Lee JM, Oh MS. A case report of Guillain-Barre syndrome. J Haehwa Med 2014;23:137-148. [in Korean].
  22. Jung ES, Yoo HR, Kim WS, Seol IC. A case report of Guillain-Barre syndrome with neutropenia improved by combined Korean medicine treatment. J Soc Stroke Korean Med 2020;21:57-66. [in Korean].
  23. Oh JY, Kim YW, Lim EC. A case-report of a Taeyangin patient with acute motor axonal neuropathy using ogapijangchuk-tang. J Sasang Constitut Med 2021;33:171-180. [in Korean].
  24. Yang MS, Jong KS, Choi JB. Current research trend on acupuncture treatment for nerve regeneration and recovery: Based on the data of Pub. Med J Acupunct Res 2014;31:147-157. [in Korean].
  25. Wang HF, Wang FC, Wang J, Zhang EL, Dong GR. Clinical observation on electroacupuncture at shu-points of the five zang-organs for treatment of acute Guillain-Barre syndrome. Chin Acupunct Moxibustion 2004;24:823-824. [in Chinese].
  26. Korean Acupuncture & Moxibustion Medicine Society Textbook Compilation Committee. Acupuncture Medicine. Seoul (Korea): Hanmi medical; 2016. 623 p.
  27. Hong YS, Hwang YJ. The Oriental Medicine Study on G-B Syndrome. Centering around the etiological factors pathological mechanism and diagnosis and treatment. J Korean Med 1995;16:118-131.
  28. Shin MS, Choi SW. Pharmacopuncturology in Musculoskeletal Disease. Goyang (Korea): Gaonhae Media;2015. 3 p.
  29. Kim JE, Kim GY. Effects of hominis placenta pharmacopuncture and electroacupuncture neuroprotection in contused spinal cord of rats. J Physiol Pathol Korean Med 2011;25:257-263.
  30. Kim WH, Lee CH, Lee JS, Cho KH, Kim SO, Cho SH et al. Anti-inflammatory activities of a herbal preparation GCSB-5 on acute and chronic inflammation. Korean J Pharmacognosy 2005;36:311-317.
  31. Lee SY, Kwon HK, Lee SM. SHINBARO, a new herbal medicine with multifunctional mechanism for joint disease: First therapeutic application for the treatment of osteoarthritis. Arch Pharm Res 2011;34:1773-1777. https://doi.org/10.1007/s12272-011-1121-0
  32. Kim TH, Yoon SJ, Lee WC, Kim JK, Shin JS, Lee SH et al. Protective effect of GCSB-5, an herbal preparation, against peripheral nerve injury in rats. J Ethnopharmacol 2011;136:297-304. https://doi.org/10.1016/j.jep.2011.04.037
  33. Marsh N, Williams V. Practical applications of snake venom toxins in hemostasis. Toxicon 2005;45:1171-1181. https://doi.org/10.1016/j.toxicon.2005.02.016
  34. Kocyigit A, Guler EM, Kaleli S. Anti-inflammatory and antioxidative properties of honey bee venom on Freund's Complete Adjuvant-induced arthritis model in rats. Toxicon 2019;161:4-11. https://doi.org/10.1016/j.toxicon.2019.02.016
  35. Kim JH, Shin HG. Analysis of biological experiment on immunoactivity of Sipjeondabo-tang. J Physiol Pathol Korean Med 2012;26:641-649. [in Korean].
  36. Lee MY, Ma JY, Choo YK, Jung KY. Protection of spontaneous and glutamate-induced neuronal damages by soeumin sibjeundaibo-tang and soyangin sibimijihwang-tang in cultured mice cerebrocortical cells. Orient Pharm Exp Med 2000;1:55-63.
  37. Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-allergic actions. Chem Pharm Bull 1992;40:1439-1442. https://doi.org/10.1248/cpb.40.1439
  38. Yokota T, Hishio H, Kubota Y, Mizoguchi M. The inhibitory of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998;11:355-361. https://doi.org/10.1111/j.1600-0749.1998.tb00494.x
  39. Rhyu MR, Kim JH, Kim EY. Radix Angelica elicits both nitric oxide-dependent and calcium influx-mediated relaxation in rat aorta. J Cardiovasc Pharmacol 2005;46:99-104. https://doi.org/10.1097/01.fjc.0000164092.88821.49
  40. Choi SS, Han KJ, Lee HK, Han EJ, Suh HW. Antinociceptive profiles of crude extract from roots of Angelica gigas Nakai in various pain models. Biol Pharm Bull 2003;26:1283-1288. https://doi.org/10.1248/bpb.26.1283
  41. He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol 2011;25:10.
  42. Chen G, Guo LX, Deng XH, Yin ZY, Jing JJ. Effects of total glucosides of paeony on nitric oxide and inducible nitric oxide synthase production in macrophages and its mechanism. Zhongguo Mian Yi Xue Za Zhi 2008;24:345. [in Chinese].
  43. Byun JY, Son YC, Um TS. A literature review on the hyeolseong of Zusanli and Chung-wan. J Acupunct Res 1992;9:173-178.
  44. Hu LN, Tian JX, Gao W, Zhu J, Mou FF, Ye XC et al. Electroacupuncture and moxibustion promote regeneration of injured sciatic nerve through Schwann cell proliferation and nerve growth factor secretion. Neural Regen Res 2018;13:477-483. https://doi.org/10.4103/1673-5374.228731
  45. da Silva MA. A neurosegmental perspective of the classical back shu points. Med Acupuncture 2010;22:257-264. https://doi.org/10.1089/acu.2010.0762
  46. Hwang EM, Wang KH, Bae JI, Keum DH. The effect of dry cupping treatment applied to back-shu points on the autonomic nervous system through HRV. J Orient Rehabil Med 2013;23:51-64.
  47. Lee YS, Lee YB, Kim CH. The preferred method for evaluation of lower extremity functional status in patients with stroke. J Korean Geriatr Soc 2006;10:192-196.
  48. Shim SY, Park HJ, Lee JM, Lee HS. An overview of pain measurements. J Meridian Acupoint 2007;24:77-97.
  49. White A. Measuring pain. Acupunct Med 1998;16:83-87. https://doi.org/10.1136/aim.16.2.83
  50. van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG Treatment and Prognosis in Guillain-Barre Syndrome. J Clinical Immunol 2010;30:74-78.